Source:http://linkedlifedata.com/resource/pubmed/id/14595393
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2003-11-3
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0268-3369
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1035
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14595393-Acyclovir,
pubmed-meshheading:14595393-Administration, Oral,
pubmed-meshheading:14595393-Drug Administration Schedule,
pubmed-meshheading:14595393-Drug Evaluation,
pubmed-meshheading:14595393-Herpes Simplex,
pubmed-meshheading:14595393-Humans,
pubmed-meshheading:14595393-Treatment Outcome,
pubmed-meshheading:14595393-Valine
|
pubmed:year |
2003
|
pubmed:articleTitle |
Dosing schedule of oral valacyclovir for prevention of herpes simplex virus.
|
pubmed:publicationType |
Letter,
Comment
|